Skip to content

Assessment of Non-alcoholic Fatty Lver Disease by Combi-elastography

Assessment of Non-alcoholic Fatty Lver Disease by Combi-elastography

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100044051
Enrollment
Unknown
Registered
2021-03-09
Start date
2021-03-09
Completion date
Unknown
Last updated
2021-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonalcoholic fatty liver disease

Interventions

Gold Standard:Pathological diagnosis
and&#32

Sponsors

China–Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: The adult patients with metabolic syndrome who plan to undergo weight loss surgery in the weight loss center of our hospital.

Exclusion criteria

Exclusion criteria: Combined with other causes of liver disease, 1. In patients with alcoholic liver disease, the amount of alcohol consumed was 140 g > per week for men and 70g b > per week for women. 2. Patients with specific diseases that can lead to fatty liver, such as viral hepatitis, drug-induced liver disease, total parenteral nutrition, hepatolenticular degeneration, autoimmune liver disease, etc.

Design outcomes

Primary

MeasureTime frame
ATT;combi-elastography;

Countries

China

Contacts

Public ContactBo Zhang

China–Japan Friendship Hospital

779053916@qq.com+86 10 84205417

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026